Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study

The Lancet Public Health

Volumn 3, Issue 3, 2018, Pages e124-e132

  Schwarzinger, Michaël ^a,b   Pollock, Bruce G ^c,d   Hasan, Omer S M ^c,d   Dufouil, Carole ^f,g   Rehm, Jürgen ^c,d,e,h   Baillot, S ⁱ   Guibert, Q ⁱ   Planchet, F ⁱ   Luchini, S ⁱ  

^a Translational Health Economics Network   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g BORDEAUX UNIVERSITY HOSPITAL   (France)

^h DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOLISM; ALZHEIMER DISEASE; ARTICLE; BINGE DRINKING; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DISEASE BURDEN; EPILEPSY; FEMALE; GLAUCOMA; HUMAN; HUNTINGTON CHOREA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; OBESITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETROSPECTIVE STUDY; SENILITY; SMOKING; VERY ELDERLY; WERNICKE KORSAKOFF SYNDROME; FRANCE; MIDDLE AGED; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALCOHOLISM; DEMENTIA; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85042198171     PISSN: None     EISSN: 24682667     Source Type: Journal    
DOI: 10.1016/S2468-2667(18)30022-7     Document Type: Article

References (31)

1. Livingston, G, Sommerlad, A, Orgeta, V, et al. Dementia prevention, intervention, and care. Lancet 390 (2017), 2673–2734.
2. Prince, M, Bryce, R, Albanese, E, Wimo, A, Ribeiro, W, Ferri, CP, The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9 (2013), 63–75 e2.
3. GBD DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1260–1344.
4. Rehm, J, Gmel, GE Sr, Gmel, G, et al. The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction 112 (2017), 968–1001.
5. Verbaten, MN, Chronic effects of low to moderate alcohol consumption on structural and functional properties of the brain: beneficial or not?. Hum Psychopharmacol 24 (2009), 199–205.
6. Topiwala, A, Allan, CL, Valkanova, V, et al. Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ, 357, 2017, j2353.
7. Oslin, D, Atkinson, RM, Smith, DM, Hendrie, H, Alcohol related dementia: proposed clinical criteria. Int J Geriatr Psychiatry 13 (1998), 203–212.
8. Gupta, S, Warner, J, Alcohol-related dementia: a 21st-century silent epidemic?. Br J Psychiatry 193 (2008), 351–353.
9. Ridley, NJ, Draper, B, Withall, A, Alcohol-related dementia: an update of the evidence. Alzheimers Res Ther, 5, 2013, 3.
10. Rehm, J, Mathers, C, Popova, S, Thavorncharoensap, M, Teerawattananon, Y, Patra, J, Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373 (2009), 2223–2233.
11. Rehm, J, Anderson, P, Barry, J, et al. Prevalence of and potential influencing factors for alcohol dependence in Europe. Eur Addict Res 21 (2015), 6–18.
12. Nordstrom, P, Nordstrom, A, Eriksson, M, Wahlund, LO, Gustafson, Y, Risk factors in late adolescence for young-onset dementia in men: a nationwide cohort study. JAMA Intern Med 173 (2013), 1612–1618.
13. Agence Technique de l'Information sur l'Hospitalisation. Aide à l'utilisation des informations de chaînage [How to use de-identified patient information]. http://www.atih.sante.fr/aide-lutilisation-des-informations-de-chainage, 2014 (accessed Feb 10, 2018).
14. St Germaine-Smith, C, Metcalfe, A, Pringsheim, T, et al. Recommendations for optimal ICD codes to study neurologic conditions: a systematic review. Neurology 79 (2012), 1049–1055.
15. Desesquelles, A, Demuru, E, Salvatore, MA, et al. Mortality from Alzheimer's disease, Parkinson's disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach. J Aging Health 26 (2014), 283–315.
16. Roman, GC, Tatemichi, TK, Erkinjuntti, T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (1993), 250–260.
17. Weuve, J, Proust-Lima, C, Power, MC, et al. Guidelines for reporting methodological challenges and evaluating potential bias in dementia research. Alzheimers Dement 11 (2015), 1098–1109.
18. Snoep, JD, Morabia, A, Hernandez-Diaz, S, Hernan, MA, Vandenbroucke, JP, Commentary: a structural approach to Berkson's fallacy and a guide to a history of opinions about it. Int J Epidemiol 43 (2014), 515–521.
19. Korn, EL, Graubard, BI, Midthune, D, Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145 (1997), 72–80.
20. Thiebaut, AC, Benichou, J, Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 23 (2004), 3803–3820.
21. Prasad, V, Jena, AB, Prespecified falsification end points: can they validate true observational associations?. JAMA 309 (2013), 241–242.
22. Letenneur, L, Gilleron, V, Commenges, D, Helmer, C, Orgogozo, JM, Dartigues, JF, Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry 66 (1999), 177–183.
23. Raffaitin, C, Gin, H, Empana, JP, et al. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care 32 (2009), 169–174.
24. Schomerus, G, Lucht, M, Holzinger, A, Matschinger, H, Carta, MG, Angermeyer, MC, The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol 46 (2011), 105–112.
25. Rehm, J, Shield, KD, Gmel, G, Rehm, MX, Frick, U, Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol 23 (2013), 89–97.
26. Flegal, KM, Keyl, PM, Nieto, FJ, Differential misclassification arising from nondifferential errors in exposure measurement. Am J Epidemiol 134 (1991), 1233–1244.
27. Albanese, E, Launer, LJ, Egger, M, et al. Body mass index in midlife and dementia: systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst) 8 (2017), 165–178.
28. Anstey, KJ, Ashby-Mitchell, K, Peters, R, Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis 56 (2017), 215–228.
29. Organisation for Economic Co-operation and Development (OECD). Tackling harmful alcohol use: economics and public health policy. 2015, Organisation for Economic Co-operation and Development (OECD), Paris.
30. Anderson, P, Chisholm, D, Fuhr, DC, Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 373 (2009), 2234–2246.
31. Persoz, C, A new President in France: an opportunity for public health policy against alcohol-related harms and deaths?. Lancet Public Health 2 (2017), e256–e257.